Searchable abstracts of presentations at key conferences in endocrinology

ea0098b14 | Basic Science | NANETS2023

Scandium-43-DOTATATE, a Novel Positron Emission Tomography (PET) Tracer for Neuroendocrine Tumor Imaging

Zhang Hannah J. , Pusateri Antonino J. , Meier Jason P. , Lakiza Olga , Bhuiyan Mohammed , Tsai Hsiu-Ming , Leoni Lara , Ghosh Kaustab , Freifelder Richard , Andy Liao Chih-Yi , Pu Yonglin , Appelbaum Daniel , Weichselbaum Ralph , Nolen Jerry , Kao Chien-Min , Rotsch David , Chen Chin-Tu , Keutgen Xavier M.

Background: Neuroendocrine tumors (NETs) represent a heterogenous group of neoplasms and their diagnosis can be challenging. In 2019, FDA approved 68Gallium labeled DOTATATE PET tracer for SSTR2 overexpressing NETs, which has been widely adopted since. However, limitations of 68Ga-DOTATATE have led to the development of additional radiotracers for the diagnosis of NETs. Herein we report on a novel PET tracer using 43Sc for DOTATATE labeling. <s...